- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06394739
RevCore for In Stent Thrombosis (REVIT)
RevCore for In Stent Thrombosis (REVIT)
The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
Study Overview
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jenifer Foss
- Phone Number: (978)-587-6598
- Email: jenifer.foss@stryker.com
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06511
- Recruiting
- Yale University
-
Contact:
- Angelo Marino, OD
-
Principal Investigator:
- Angelo Marino, OD
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20010
- Recruiting
- Medstar Health Research Institute
-
Principal Investigator:
- Kyle Reynolds, MD
-
Sub-Investigator:
- Steven Abramowitz
-
Contact:
- Kyle Reynolds, MD
-
-
Idaho
-
Boise, Idaho, United States, 83712
- Recruiting
- St. Luke's Hospital Boise
-
Contact:
- Tyler Harris, MD
-
Principal Investigator:
- Tyler Harris, MD
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Active, not recruiting
- University of Maryland
-
-
New York
-
New York, New York, United States, 10016
- Recruiting
- New York University- Langone
-
Principal Investigator:
- Mikel Sadek, MD
-
Contact:
- Mikel Sadek, MD
-
-
North Carolina
-
Asheville, North Carolina, United States, 28801
- Recruiting
- Mission Health
-
Principal Investigator:
- Trevor Downing, MD
-
Contact:
- Trevor Downing, MD
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- Recruiting
- UH Cleveland Medical Center
-
Principal Investigator:
- Karem Harth, MD
-
Contact:
- Karem Harth, MD
-
Columbus, Ohio, United States, 23210
- Recruiting
- Ohio State University
-
Principal Investigator:
- Mina Makary, MD
-
Contact:
- Mina Makary, MD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- University of Pennsylvania
-
Contact:
- Ryan Cobb, MD
-
Principal Investigator:
- Ryan Cobb, MD
-
Philadelphia, Pennsylvania, United States, 19107
- Withdrawn
- Thomas Jefferson University
-
Pittsburgh, Pennsylvania, United States, 15212
- Recruiting
- Allegheny Health Network Research Institute
-
Contact:
- Abdullah Shaikh, MD
-
Principal Investigator:
- Abdullah Shaikh, MD
-
-
South Carolina
-
Spartanburg, South Carolina, United States, 29303
- Recruiting
- Spartanburg Medical Center
-
Principal Investigator:
- Brian Brown, MD
-
Contact:
- Brian Brown, MD
-
-
Texas
-
El Paso, Texas, United States, 79902
- Recruiting
- El Paso Cardiology Associates
-
Contact:
- Waseem Shami, MD
-
Principal Investigator:
- Waseem Shami, MD
-
Plano, Texas, United States, 75093
- Recruiting
- Baylor Scott & White Research Institute
-
Contact:
- Joseph Liechty, MD
-
-
Virginia
-
Norfolk, Virginia, United States, 23507
- Recruiting
- Sentara
-
Principal Investigator:
- David Dexter, MD
-
Contact:
- David Dexter, MD
-
-
Washington
-
Seattle, Washington, United States, 98133
- Recruiting
- University of Washington
-
Contact:
- Jake Hemingway, MD
-
Principal Investigator:
- Jake Hemingway, MD
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26506
- Recruiting
- West Virginia University- Ruby Memorial
-
Contact:
- Robert Grammer, MD
-
Principal Investigator:
- Robert Grammer, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Up to 100 subjects with in-stent thrombosis will be enrolled. All subjects who sign informed consent and who meet all of the inclusion criteria and none of the exclusion criteria will be eligible to participate in the study.
Description
Inclusion Criteria:
- Age ≥ 18 years
- Patients with stent age > 6 weeks
- Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein
- RevCore Thrombectomy Catheter must enter vasculature
- Willing and able to provide informed consent
Exclusion Criteria:
- Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel
- Stents not wall apposed
- Stents compressed to <10mm
- Bilateral in-stent thrombosis
- Congenital anatomic anomalies of the iliac veins
- Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used
- Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period
- Chronic non-ambulatory status
- Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period
- Inability to secure venous access
- Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject
- Current participation in another investigational drug or device treatment study
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evidence of successful stent recanalization
Time Frame: Immediately after the RevCore thrombectomy procedure for in-stent thrombosis
|
Defined as patency ≥50% luminal diameter utilizing intravascular ultrasound (IVUS) |
Immediately after the RevCore thrombectomy procedure for in-stent thrombosis
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-002 REVIT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.